A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson's disease

Current Medical Research and Opinion
J WajsbortE Wajsbort

Abstract

The therapeutic effect of the combination of levodopa and carbidopa ("Sinemet") was compared with that of levodopa alone in 21 patients with Parkinson's disease. Eighteen parameters of the clinical condition and of functional impairment were determined quantitatively and the results satistically evaluated. Changing over from levodopa to the combination preparation resulted in an average improvement of 51.9% within 2 weeks. No relationship was found to exist between the degree of improvement and the severity or the progression of the disease. By the use of the combination preparation, the daily dosage of levodopa could be reduced by 77%. Side-effects connected with the gastro-intestinal tract occurred much less frequently, while hyperkinesia increased. No arrhythmogenic effect was found with the combination product. From the clinical standpoint, combination therapy appeared to be qualitatively superior. By selective maintenance of freshly formed dopamine, it should be possible to assure a directed influence on the disturbed equilibrium of the functional systems of the brain.

References

Sep 13, 1975·Lancet·P F TeychenneA N Bamji
Jan 1, 1977·Journal of Immunological Methods·J J van der Poel, B A Bradley
May 1, 1976·Neurology·J S FeigensonF H McDowell
Mar 22, 1975·British Medical Journal·R H Livingstone, R I Wilson
Sep 1, 1975·Postgraduate Medical Journal·E Critchley
Jun 1, 1972·The Journal of Dairy Research·R L Lyster
Dec 7, 1974·Lancet·D B CalneJ K Greenacre
Feb 13, 1969·The New England Journal of Medicine·G C CotziasR Gellene
Jan 1, 1970·Dermatologica·P D Mier, E Urselmann
Jan 1, 1972·Journal of Neural Transmission·W BirkmayerP Riederer
Jan 1, 1973·British Journal of Plastic Surgery·B S Crawford, C Vivakananthan
Jun 1, 1973·Journal of Personality Assessment·L Whitaker
Aug 1, 1973·European Journal of Pharmacology·H H KellerA Pletscher
Feb 1, 1970·Biochemical Medicine·T L Sourkes
Apr 1, 1972·Neurology·T N Chase, A M Watanabe
Dec 20, 1971·JAMA : the Journal of the American Medical Association·I MenaG C Cotzias
Feb 16, 1967·The New England Journal of Medicine·G C CotziasL M Schiffer
Jan 1, 1970·Annals of Internal Medicine·F McDowellJ T Kessler
Nov 21, 1970·British Medical Journal·N Krasner, J M Cornelius
Mar 1, 1971·Clinical Pharmacology and Therapeutics·G C CotziasS Düby
Mar 1, 1971·Clinical Pharmacology and Therapeutics·C H Markham
Mar 1, 1971·Clinical Pharmacology and Therapeutics·A Pletscher, G Bartholini
Jan 1, 1967·Medicina Et Pharmacologia Experimentalis. International Journal of Experimental Medicine·B DjahanguiriA Firouzabadi
May 1, 1967·Neurology·M M Hoehn, M D Yahr
May 26, 1961·Science·A BARBEAUT L SOURKES
Aug 1, 1961·The Journal of Nervous and Mental Disease·G J CANTERM MIER
Jan 1, 1962·Archiv für Psychiatrie und Nervenkrankheiten, vereinigt mit Zeitschrift für die gesamte Neurologie und Psychiatrie·W BIRKMAYER, O HORNYKIEWICZ

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.